Gene · 406959
Papers3,243
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,243
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An ultra-sensitive suboptimal protospacer adjacent motif enhanced rolling circle amplification assay based on CRISPR/Cas12a for detection of miR-183. | Front Bioeng Biotechnol | 2024 | 39359259 | PubTator, text mining | PubMed |
| Crosstalk between MIR-96 and IRS/PI3K/AKT/VEGF cascade in hRPE cells; A potential target for preventing diabetic retinopathy. | PLoS One | 2024 | 39348384 | PubTator, text mining | PubMed |
| Circulating microRNAs in Carotid Atherosclerosis: Complex Interplay and Possible Associations with Atherothrombotic Stroke. | Int J Mol Sci | 2024 | 39337512 | PubTator, text mining | PubMed |
| Genotype Characterization and MiRNA Expression Profiling in Usher Syndrome Cell Lines. | Int J Mol Sci | 2024 | 39337481 | PubTator, text mining | PubMed |
| Retraction: miR-183 modulates cell apoptosis and proliferation in tongue squamous cell carcinoma SCC25 cell line. | Oncol Res | 2024 | 39308525 | PubTator, text mining | PubMed |
| Strategic targeting of miR-183 and β-catenin to enhance BMSC stemness in age-related osteoporosis therapy. | Sci Rep | 2024 | 39277663 | PubTator, text mining | PubMed |
| Unraveling the relevance of SARS-Cov-2 infection and ferroptosis within the heart of COVID-19 patients. | Heliyon | 2024 | 39263089 | PubTator, text mining | PubMed |
| Suppression of neuronal CDK9/p53/VDAC signaling provides bioenergetic support and improves post-stroke neuropsychiatric outcomes. | Cell Mol Life Sci | 2024 | 39235466 | PubTator, text mining | PubMed |
| CmirC update 2024: a multi-omics database for clustered miRNAs. | Funct Integr Genomics | 2024 | 39085735 | PubTator, text mining | PubMed |
| Downregulated expression of lncRNA TUBA4B predicts unfavorable prognosis and suppresses glioma progression by sponging miR-183 to regulate SMAD4 expression. | Arch Med Sci | 2024 | 39050167 | PubTator, text mining | PubMed |
| Long noncoding RNA profiling unveils LINC00960 as unfavorable prognostic biomarker promoting triple negative breast cancer progression. | Cell Death Discov | 2024 | 39039064 | PubTator, text mining | PubMed |
| Targeted genome editing restores auditory function in adult mice with progressive hearing loss caused by a human microRNA mutation. | Sci Transl Med | 2024 | 38985856 | PubTator, text mining | PubMed |
| Deciphering the molecular landscape of ionising radiation-induced eye damage with the help of genomic data mining. | Arh Hig Rada Toksikol | 2024 | 38963141 | PubTator, text mining | PubMed |
| Publisher Correction: MiR-21 and miR-183 can simultaneously target SOCS6 and modulate growth and invasion of hepatocellular carcinoma (HCC) cells. | Eur Rev Med Pharmacol Sci | 2024 | 38766781 | PubTator, text mining | PubMed |
| Discovery and Validation of Novel microRNA Panel for Non-Invasive Prediction of Prostate Cancer. | Cureus | 2024 | 38741808 | PubTator, text mining | PubMed |
| Differential analysis of histopathological and genetic markers of cancer aggressiveness, and survival difference in EBV-positive and EBV-negative prostate carcinoma. | Sci Rep | 2024 | 38705879 | PubTator, text mining | PubMed |
| Systematic review and meta-analysis of dysregulated microRNAs derived from liquid biopsies as biomarkers for amyotrophic lateral sclerosis. | Noncoding RNA Res | 2024 | 38511059 | PubTator, text mining | PubMed |
| The value of a panel of circulating microRNAs in screening prostate cancer. | Transl Cancer Res | 2024 | 38482417 | PubTator, text mining | PubMed |
| Epigenetic Switches in Retinal Homeostasis and Target for Drug Development. | Int J Mol Sci | 2024 | 38474086 | PubTator, text mining | PubMed |
| Identification of two hub genes and miRNA‑mRNA interactions in chronic obstructive pulmonary disease (COPD) plasma. | J Asthma | 2024 | 38411985 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406959/papers?page=5